Cover Image

Altered IL-7 signaling in CD4+ T cells from patients with visceral leishmaniasis.

<h4>Background</h4>CD4+ T cells play a central role in control of L. donovani infection, through IFN-γ production required for activation of macrophages and killing of intracellular parasites. Impaired control of parasites can in part be explained by hampered CD4+ T cells effector functi...

Full description

Saved in:

Bibliographic Details
Main Authors:	Shashi Kumar (Author), Shashi Bhushan Chauhan (Author), Shreya Upadhyay (Author), Siddharth Sankar Singh (Author), Vimal Verma (Author), Rajiv Kumar (Author), Christian Engwerda (Author), Susanne Nylén (Author), Shyam Sundar (Author)
Format:	Book
Published:	Public Library of Science (PLoS), 2024-02-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Phenotypic and functional characteristics of monocyte subsets in the blood and bone marrow of Indian subjects with Visceral Leishmaniasis.
by: Gulafsha Kausar, et al.
Published: (2024)

Combined Immune Therapy for the Treatment of Visceral Leishmaniasis.
by: Rebecca J Faleiro, et al.
Published: (2016)

Leishmania specific CD4 T cells release IFNγ that limits parasite replication in patients with visceral leishmaniasis.
by: Rajiv Kumar, et al.
Published: (2014)

Immune regulation during chronic visceral leishmaniasis.
by: Rebecca J Faleiro, et al.
Published: (2014)

Wuchereria bancrofti infection is associated with progression to clinical visceral leishmaniasis in VL- endemic areas in Muzaffarpur, Bihar, India.
by: Abhishek Kumar Singh, et al.
Published: (2023)

Livestock and rodents within an endemic focus of Visceral Leishmaniasis are not reservoir hosts for Leishmania donovani.
by: Anurag Kumar Kushwaha, et al.
Published: (2022)

Meta-taxonomic analysis of prokaryotic and eukaryotic gut flora in stool samples from visceral leishmaniasis cases and endemic controls in Bihar State India.
by: Rachael Lappan, et al.
Published: (2019)

Xenodiagnosis to address key questions in visceral leishmaniasis control and elimination.
by: Om Prakash Singh, et al.
Published: (2020)

Quantitative PCR in epidemiology for early detection of visceral leishmaniasis cases in India.
by: Medhavi Sudarshan, et al.
Published: (2014)

Drug susceptibility in Leishmania isolates following miltefosine treatment in cases of visceral leishmaniasis and post kala-azar dermal leishmaniasis.
by: Vasundhra Bhandari, et al.
Published: (2012)

Significantly lower anti-Leishmania IgG responses in Sudanese versus Indian visceral leishmaniasis.
by: Tapan Bhattacharyya, et al.
Published: (2014)

Visceral leishmaniasis and arsenic: an ancient poison contributing to antimonial treatment failure in the Indian subcontinent?
by: Meghan R Perry, et al.
Published: (2011)

Post kala-azar dermal leishmaniasis: A threat to elimination program.
by: Mallikarjuna Rao Gedda, et al.
Published: (2020)

Visceral leishmaniasis in the Indian subcontinent: modelling epidemiology and control.
by: Anette Stauch, et al.
Published: (2011)

Cost-effectiveness analysis of combination therapies for visceral leishmaniasis in the Indian subcontinent.
by: Filip Meheus, et al.
Published: (2010)

The Severity of Visceral Leishmaniasis Correlates with Elevated Levels of Serum IL-6, IL-27 and sCD14.
by: Priscila L Dos Santos, et al.
Published: (2016)

Cytokine responses to novel antigens in an Indian population living in an area endemic for visceral leishmaniasis.
by: Om Prakash Singh, et al.
Published: (2012)

Visceral leishmaniasis elimination programme in India, Bangladesh, and Nepal: reshaping the case finding/case management strategy.
by: Dinesh Mondal, et al.
Published: (2009)

Altered co-stimulatory and inhibitory receptors on monocyte subsets in patients with visceral leishmaniasis.
by: Emebet Adem, et al.
Published: (2024)

Disease severity in patients with visceral leishmaniasis is not altered by co-infection with intestinal parasites.
by: Fitsumbrhan Tajebe, et al.
Published: (2017)

Transcriptional blood signatures for active and amphotericin B treated visceral leishmaniasis in India.
by: Michaela Fakiola, et al.
Published: (2019)

Visceral leishmaniasis complicating idiopathic CD4+ T-cell lymphocytopenia: 2 case reports.
by: Andrew Fox-Lewis, et al.
Published: (2017)

sCD163 levels as a biomarker of disease severity in leprosy and visceral leishmaniasis.
by: Ricardo Luís Louzada Silva, et al.
Published: (2017)

Treatment of visceral leishmaniasis: model-based analyses on the spread of antimony-resistant L. donovani in Bihar, India.
by: Anette Stauch, et al.
Published: (2012)

Post-kala-azar dermal leishmaniasis developing in miltefosine-treated visceral leishmaniasis
by: Sankha Koley, et al.
Published: (2013)

No evidence for association between <it>SLC11A1 </it>and visceral leishmaniasis in India
by: Fakiola Michaela, et al.
Published: (2011)

Efficacy and safety of amphotericin B emulsion versus liposomal formulation in Indian patients with visceral leishmaniasis: a randomized, open-label study.
by: Shyam Sundar, et al.
Published: (2014)

Pharmacotherapeutic Options for Visceral Leishmaniasis-Current Scenario
by: Krishna Pandey MD, et al.
Published: (2009)

Visceral leishmaniasis: Spatiotemporal heterogeneity and drivers underlying the hotspots in Muzaffarpur, Bihar, India.
by: Caroline A Bulstra, et al.
Published: (2018)

Options for active case detection of visceral leishmaniasis in endemic districts of India, Nepal and Bangladesh, comparing yield, feasibility and costs.
by: Shri Prakash Singh, et al.
Published: (2011)

Model-based investigations of different vector-related intervention strategies to eliminate visceral leishmaniasis on the Indian subcontinent.
by: Anette Stauch, et al.
Published: (2014)

Relationship between treatment regimens for visceral leishmaniasis and development of post-kala-azar dermal leishmaniasis and visceral leishmaniasis relapse: A cohort study from Bangladesh.
by: Dinesh Mondal, et al.
Published: (2019)

Correction: Recombinant NAD-dependent SIR-2 protein of Leishmania donovani: immunobiochemical characterization as a potential vaccine against visceral leishmaniasis.
by: Rajendra K Baharia, et al.
Published: (2015)

Epidemiology of visceral leishmaniasis in Georgia.
by: Giorgi Babuadze, et al.
Published: (2014)

Glomerulopathy Associated with Visceral leishmaniasis
by: Sh Khademvatan, et al.
Published: (2007)

Glomerulopathy Associated with Visceral leishmaniasis
by: Sh Khademvatan, et al.
Published: (2007)

Clinical Case. Visceral Leishmaniasis
by: I.V. Bogadelnikov, et al.
Published: (2014)

Male predominance in reported Visceral Leishmaniasis cases: Nature or nurture? A comparison of population-based with health facility-reported data.
by: Kristien Cloots, et al.
Published: (2020)

IgG1 as a potential biomarker of post-chemotherapeutic relapse in visceral leishmaniasis, and adaptation to a rapid diagnostic test.
by: Tapan Bhattacharyya, et al.
Published: (2014)

Single-dose liposomal amphotericin B: an effective treatment for visceral leishmaniasis
by: Prabhat Kumar Sinha, et al.
Published: (2014)